Evidence map›Paper›PMID 41965857›Full record

ArticleNature communications2026

Characterizing gene perturbations in single cells via network divergence analysis.

Chao Huang, Yuhan Li, Botao Fa, Jinglin Zhu, Zhenni Liu, Yixin Ma, Zhitao Zhang, Yungang Xu, Qiuran Xu, Zhengtao Xiao

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chao Huang *Institute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.ORCID http://orcid.org/0000-0003-1186-0973
Yuhan Li *Institute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Botao Fa *Institute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.ORCID http://orcid.org/0009-0009-0973-9366
Jinglin ZhuCollege of Medicine, Yan'an University, Yan'an, Shaanxi, China.
Zhenni LiuInstitute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Yixin MaInstitute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.ORCID http://orcid.org/0009-0006-9262-8832
Zhitao ZhangInstitute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.ORCID http://orcid.org/0009-0009-2012-3263
Yungang XuDepartment of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China. yungang.xu@xjtu.edu.cn.ORCID http://orcid.org/0000-0002-9834-3006
Qiuran XuZhejiang Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. xuqiuran@hmc.edu.cn.ORCID http://orcid.org/0000-0003-2171-9279
Zhengtao XiaoInstitute of Molecular and Translational Medicine (IMTM), Department of Biochemistry and Molecular Biology (DBMB), Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China. zhengtao.xiao@xjtu.edu.cn.ORCID http://orcid.org/0000-0002-5535-5381

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32200522National Natural Science Foundation of China (National Science Foundation of China) 32370706National Natural Science Foundation of China (National Science Foundation of China) 82541006
6 · The paper itself

Abstract

Functional perturbations of genes do not always cause expression changes, but can manifest through network rewiring or context-specific shifts in regulatory activity. However, inferring functional shifts in genes and linking them to the specific cell populations remains challenging, as most current scRNA-seq data analysis focuses either on differential gene expression or on cell abundance/state changes, but rarely associate gene perturbations with particular cell populations. Here we present scDNS, a framework that quantifies gene-specific functional perturbations by measuring information-theoretic divergence between condition-specific gene interaction network configurations. In simulated stress tests and multiple experimental datasets, scDNS prioritizes key regulators and perturbed cell populations, even when expression changes are minimal but network rewiring is pronounced. Applications to immunodeficiency mutations, stimulus responses, and viral infection reveal hidden regulatory programs and heterogeneous responder cell states. In pancreatic cancer, scDNS nominates TIMM44 as a mitochondrial sensitizer enhancing gemcitabine efficacy. Together, scDNS provides a powerful tool for inferring dynamic gene perturbations in single cells.

Indexed as

Gene Regulatory NetworksSingle-Cell AnalysisAnimalsGemcitabineHumansPancreatic NeoplasmsSingle-Cell Gene Expression AnalysisGemcitabine

Identifiers

PMID41965857
PMCPMC13249949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.